NeuroPace NPCE
NASDAQ NPCE
$14.50 -0.26 (-1.76%)
As of: Sep 9, 2026 · 3:59 PM EDT

NeuroPace (NPCE) Property, Plant & Equipment (Net) (2020 - 2026)

Analysis

NeuroPace (NPCE) Property, Plant & Equipment (Net) (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn 12.81 Bn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 5.55 Bn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 7.47 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 3.96 Bn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 4.13 Bn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 1.84 Bn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn 4.74 Bn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 1.58 Bn
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn 2.17 Bn
10 NeuroPace 510.81 Mn 459.11 Mn 18.91 Mn 1.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.24 Mn
Mar 31, 2026 1.28 Mn
Dec 31, 2025 1.13 Mn
Sep 30, 2025 1.11 Mn
Jun 30, 2025 1.16 Mn
Mar 31, 2025 1.16 Mn
Dec 31, 2024 1.05 Mn
Sep 30, 2024 1.04 Mn
Jun 30, 2024 998,000.00
Mar 31, 2024 1.05 Mn
Dec 31, 2023 1.00 Mn
Sep 30, 2023 949,000.00
Jun 30, 2023 976,000.00
Mar 31, 2023 1.02 Mn
Dec 31, 2022 1.06 Mn
Sep 30, 2022 894,000.00
Jun 30, 2022 951,000.00
Mar 31, 2022 860,000.00
Dec 31, 2021 603,000.00
Sep 30, 2021 624,000.00